About GENVARA BIOPHARMA, INC.
Genvara Biopharma Inc is a company focused on developing pharmacogenetically-targeted cardiovascular drugs through novel mechanisms of action. Their lead late-stage asset, GENCARO, is a Phase 3-ready therapy for atrial fibrillation in heart failure patients.
Development of pharmacogenetically-targeted cardiovascular drugsBasic and clinical research in human cardiac systemsDrug development and clinical trialsMolecular genetics and molecular pharmacology expertise
Is this your company?
Claim GENVARA BIOPHARMA, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim GENVARA BIOPHARMA, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.